Browse by Basel Contributors ID

Group by: Date | Item Type | Refereed | No Grouping

Jump to: Yes

Yes

Imhof, A. and Brunner, P. and Marincek, N. and Briel, M. and Schindler, C. and Rasch, H. and Macke, H. R. and Rochlitz, C. and Muller-Brand J., and Walter, M. A.. (2011) Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 29, H. 17. pp. 2416-2423.

Kretzschmar, Martin and Wiewiorski, Martin and Rasch, Helmut and Jacob, Augustinus L. and Bilecen, Deniz and Walter, Martin A. and Valderrabano, Victor. (2011) 99mTc-DPD-SPECT/CT predicts the outcome of imaging-guided diagnostic anaesthetic injections : a prospective cohort study. European journal of radiology, Vol. 80, H. 3 , e410-5.

Frank-Raue, Karin and Rybicki, Lisa A. and Erlic, Zoran and Schweizer, Heiko and Winter, Aurelia and Milos, Ioana and Toledo, Sergio P. A. and Toledo Rodrigo, A. and Tavares Marcos, R. and Alevizaki, Maria and Mian, Caterina and Siggelkow, Heide and Hüfner, Michael and Wohllk, Nelson and Opocher, Giuseppe and Dvo áková, Sárka and Bendlova, Bela and Czetwertynska, Ma gorzata and Skasko, El bieta and Barontini, Marta and Sanso, Gabriela and Vorländer, Christian and Maia, Ana Luiza and Patocs, Attila and Links Thera, P. and de Groot, Jan Willem and Kerstens Michiel, N. and Valk Gerlof, D. and Miehle, Konstanze and Musholt, Thomas J. and Biarnes, Josefina and Damjanovic, Svetozar and Muresan, Mihaela and Wüster, Christian and Fassnacht, Martin and Peczkowska, Mariola and Fauth, Christine and Golcher, Henriette and Walter, Martin A. and Pichl, Josef and Raue, Friedhelm and Eng, Charis and Neumann, Hartmut P. H.. (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Human mutation, Vol. 32, H. 1. pp. 51-58.

Walter, Franziska and Federman, Noah and Apichairuk, Wipapat and Nelson, Scott and Phelps, Michael E. and Allen-Auerbach, Martin and Walter, Martin A. and Czernin, Johannes. (2011) 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients. Pediatric haematology and oncology, Vol. 28, H. 7. pp. 579-587.

Grozinsky-Glasberg, Simona and Barak, Dganit and Fraenkel, Merav and Walter, Martin A. and Müeller-Brand, Jan and Eckstein, Joseph and Applebaum, Liat and Shimon, Ilan and Gross, David J.. (2011) Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas. Cancer, Vol. 117, H. 7. pp. 1377-1385.

Walter, Martin A. and Benz, Matthias R. and Hildebrandt, Isabel J. and Laing, Rachel E. and Hartung, Verena and Damoiseaux, Robert D. and Bockisch, Andreas and Phelps, Michael E. and Czernin, Johannes and Weber, Wolfgang A.. (2011) Metabolic imaging allows early prediction of response to vandetanib. Journal of nuclear medicine, Vol. 52, H. 2. pp. 231-240.

Walter, Martin A. and Hildebrandt, Isabel J. and Hacke, Katrin and Kesner, Adam L. and Kelly, Owen and Lawson, Gregory W. and Phelps, Michael E. and Czernin, Johannes and Weber, Wolfgang A. and Schiestl, Robert H.. (2010) Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. Journal of nuclear medicine, Vol. 51, H. 8. pp. 1285-1292.

Fueger, Barbara J. and Czernin, Johannes and Cloughesy, Timothy and Silverman, Daniel H. and Geist, Cheri L. and Walter, Martin A. and Schiepers, Christiaan and Nghiemphu, Phioanh and Lai, Albert and Phelps, Michael E. and Chen, Wei. (2010) Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Journal of nuclear medicine, Vol. 51, H. 10. pp. 1532-1538.

Walter, Martin A. and Meier, Christian and Radimerski, Tanja and Iten, Fabienne and Kränzlin, Marius and Müller-Brand, Jan and de Groot, Jan Willem B. and Kema, Ido P. and Links, Thera P. and Müller, Beat. (2010) Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer, 116 (1). pp. 31-40.